Pfizer Current tax assets decreased by 9.6% to $3.59B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.7%, from $2.90B to $3.59B. Over 5 years (FY 2020 to FY 2025), Current tax assets shows an upward trend with a 4.0% CAGR.
non_current_assets_other_tax_assets_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.76B | $3.88B | $4.27B | $3.12B | $2.58B | $2.54B | $3.58B | $3.14B | $3.19B | $3.92B | $3.98B | $4.23B | $3.69B | $3.24B | $3.31B | $2.90B | $4.02B | $3.86B | $3.97B | $3.59B |
| QoQ Change | — | +3.1% | +10.0% | -26.9% | -17.1% | -1.5% | +40.6% | -12.2% | +1.7% | +22.6% | +1.6% | +6.4% | -12.7% | -12.2% | +2.2% | -12.5% | +38.5% | -4.0% | +2.9% | -9.6% |
| YoY Change | — | — | — | — | -31.3% | -34.4% | -16.2% | +0.7% | +23.7% | +54.0% | +11.2% | +34.8% | +15.7% | -17.2% | -16.7% | -31.5% | +8.7% | +18.9% | +19.7% | +23.7% |